Myriad Genetics reported a cybersecurity incident involving unauthorized access to its IT network, which was detected on November 2, 2026. In response, the company temporarily suspended its testing operations and order management systems to contain the event. An investigation is currently underway to determine the full scope of the incident, including a review of whether any patient information was accessed.
Key Details
- Event Date: The unauthorized access was detected on November 2, 2026.
- Operational Impact: The company initiated its incident response plan, which included temporarily shutting down its testing operations and order management systems. Most systems have since returned to normal operations.
- Ongoing Investigation: An investigation, supported by external experts, is in progress to assess the nature and scope of the breach, including potential access to patient data.
- Company Outlook: As of the filing date, the company stated it does not believe the incident will have a material adverse effect on its business.